Africa News Service (01/05/99)
The Western Cape of South Africa will continue a pilot program
providing AZT to HIV-infected pregnant women despite Health
Minister Nkosazana Zuma's decision not to continue the program
nationwide. Fareed Abdullah, the chief director of health
care in the Western Cape, said that "this is not in
contradiction to national policy," and that the department
decided to continue the program because the national Health
Department had agreed to AZT trials. Abdullah added that the
program was specific to the region, noting that the cost for
hospital beds for HIV-infected children was higher in the
Western Cape than in other provinces. The cost of treating HIV
-infected women with AZT in the Western Cape was lower than
treating infected babies. Furthermore, the infant mortality
rate is elevated in the region and could increase up to 30
percent without the AZT program. The project--which includes
HIV testing, counseling, AZT treatment, milk formula for six
months, and follow-up testing for infants--is expected to run
at least 12 months, treating about 5,000 women.